[1]
“Design, Optimization and In vitro Evaluation of Mesalazine 400 mg Delayed Release Tablet for Colon Specific Delivery”, Dhaka Univ. J. Pharm. Sci, vol. 22, no. 2, pp. 189–201, Dec. 2023, doi: 10.3329/dujps.v22i2.69325.